| Literature DB >> 18430200 |
Candice C Bowman1, Elisa J Sobo, Steven M Asch, Allen L Gifford.
Abstract
As more quality improvement programs are implemented to achieve gains in performance, the need to evaluate their lasting effects has become increasingly evident. However, such long-term follow-up evaluations are scarce in healthcare implementation science, being largely relegated to the "need for further research" section of most project write-ups. This article explores the variety of conceptualizations of implementation sustainability, as well as behavioral and organizational factors that influence the maintenance of gains. It highlights the finer points of design considerations and draws on our own experiences with measuring sustainability, framed within the rich theoretical and empirical contributions of others. In addition, recommendations are made for designing sustainability analyses. This article is one in a Series of articles documenting implementation science frameworks and approaches developed by the U.S. Department of Veterans Affairs Quality Enhancement Research Initiative (QUERI).Entities:
Year: 2008 PMID: 18430200 PMCID: PMC2390585 DOI: 10.1186/1748-5908-3-21
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
The VA Quality Enhancement Research Initiative (QUERI)
| The U.S. Department of Veterans Affairs' (VA) Quality Enhancement Research Initiative (QUERI) was launched in 1998. QUERI was designed to harness VA's health services research expertise and resources in an ongoing system-wide effort to improve the performance of the VA healthcare system and, thus, quality of care for veterans. |
| QUERI researchers collaborate with VA policy and practice leaders, clinicians, and operations staff to implement appropriate evidence-based practices into routine clinical care. They work within distinct disease- or condition-specific QUERI Centers and utilize a standard six-step process: |
| 1) Identify high-risk/high-volume diseases or problems. |
| 2) Identify best practices. |
| 3) Define existing practice patterns and outcomes across the VA and current variation from best practices. |
| 4) Identify and implement interventions to promote best practices. |
| 5) Document that best practices improve outcomes. |
| 6) Document that outcomes are associated with improved health-related quality of life. |
| Within Step 4, QUERI implementation efforts generally follow a sequence of four phases to enable the refinement and spread of effective and sustainable implementation programs across multiple VA medical centers and clinics. The phases include: |
| 1) Single site pilot, |
| 2) Small scale, multi-site implementation trial, |
| 3) Large scale, multi-region implementation trial, and |
| 4) System-wide rollout. |
QUERI-HIV/Hepatitis implementation project summary
| Background: | Although studies have shown that real-time computerized clinical reminders (CR) modestly improve essential chronic disease care processes, no studies have compared the separate and combined effects of CR and group-based quality improvement (GBQI) collaboratives. |
| Objectives: | To evaluate CR, GBQI, and the interaction of the two in improving HIV quality (Step 4, Phase 2 per the QUERI framework). |
| Methods: | Using a quasi-experimental design, 4091 patients in 16 VA facilities were stratified into four groups: CR, GBQI, CR+GBQI, and controls. CR facilities received software and technical assistance in implementing real time reminders. GBQI facilities participated in a year-long collaborative emphasizing rapid cycle quality improvement targets of their choice. Ten predefined clinical endpoints included the receipt of highly active antiretroviral (ARV) therapy, screening and prophylaxis for opportunistic infection, as well as monitoring of immune function and viral load. Optimal overall care was defined as receiving all care for which the patient was eligible. Interventional effects were estimated using clustered logistic regression, controlling for clinical and facility characteristics. Human subjects' protection approval was obtained. |
| Results: | Compared to controls, CR facilities improved the likelihood of hepatitis A, toxoplasma, and lipid screening. GBQI alone improved the likelihood of pneumocystis pneumonia prophylaxis, immune-monitoring on ARVs – but reduced the likelihood of hepatitis B screening. CR+GBQI facilities improved hepatitis A and toxoplasma screening, as well as immune-monitoring on ARV. CR+GBQI facilities improved the proportion of patients receiving optimal overall care (OR = 2.65; CI: 1.16–6.0), while either modality alone did not. |
| Conclusions: | The effectiveness of CR and GBQI interventions varied by endpoint. The combination of the two interventions was effective in improving overall optimal care quality. |
| Objectives: | To ascertain whether the implemented interventions were sustained and became part of routine care, we measured the original outcomes for one additional year and evaluated continued intervention use at selected sites. |
| Methods: | Interviews with key informants selected from the study sites revealed that some sites had ceased using the interventions, and some control sites had adopted them; analyzing odds of patients receiving guideline-based HIV care (HIVGBC) compared to controls no longer made sense. Thus, we evaluated sustained performance as follows: At the facility-rather than the arm-level, we examined raw rates of patients receiving HIVGBC at only those facilities in the intervention arms that had significant effects in the study year to determine whether they continued to show a significant increase in these rates in the following year, compared to their raw rate at baseline. We also conducted a qualitative component. Based on formative evaluation results assessing the use and usefulness of the reminders, we asked informants if identified barriers were subsequently removed and recommendations heeded. Also, we evaluated the extent to which staff members from the sites that participated in the collaboratives were still conducting rapid-cycle improvement methods to address local care quality problems; whether they still maintained the social networks established during the original study, and the degree to which they were used to disseminate subsequent quality improvement change ideas, and shared network contacts with – and taught the method to new staff. |
| Results: | For hepatitis A screening, we found that 4 out of the 5 sites that showed a significant increase in their raw rate at 12 months, also showed a significant increase in their raw rate at 24 months compared to baseline (p = .05). For the other four significant indicators of HIVGBC (hepatitis C and toxoplasma screening, CD4/viral load and lipids monitoring), all sites that showed significant increases in their raw performance rates at 12 months, showed a significant increase in their raw rates at 24 months compared to baseline. |
| Conclusions: | Intervention effects were sustained for one year at nearly all the sites that showed significant increases in performance during the study period. Nearly all sites exposed to reminders were using at least some of the 10 available in the follow-up year. Collaborative methods were still being used, but only at the most activated of the original study sites. |
Figure 1Three possible outcomes of performance improvement: Successful, failed, and enhanced. (T1 = baseline period, T2 = implementation period, T3 = follow-up period).
Examples of studies reporting follow-up evaluation of implemented interventions
| Knox et al., 2003 [46] | Quasi-experiment, pre-post comparison | Multi-component suicide prevention program | USAF personnel (patient-level) | 1 year | Relative suicide risk factor rates | 1 year |
| Harland et al., 1999 [47] | RCT, pre-post comparison | 1–6 motivational interviews, with or without financial incentive | General medicine practice patients (patient-level) | 3 months | Self-reported physical activity | 1 year |
| Shye et al., 2004 [48] | Multi-faceted intervention trial, pre-post comparison | (1) Basic strategy: guideline, education, clinical supports | HMO PCPs (provider-level) | 10 months | Rates of female patients who asked about domestic violence | 3 months |
| Sanci et al., 2000, 2005 [49,50] | RCT, pre-post comparison | Multi-faceted adolescent health education program | General medicine practice physicians (provider-level) | 3 months | Observer ratings of skills, self-perceived competency, tested knowledge | 4 months, 10 months, 5 years |
| Perlstein et al., 2000 [51] | Pre-post comparison | Implemented bronchiolitis care guideline | Pediatricians who cared for infants 0–1 year hospitalized with bronchiolitis (provider-level) | -- | Patient volumes, length of stay, use of ancillary resources | 3 years |
| Brand et al., 2005 [52] | Program evaluation | COPD management guideline | Hospital physicians (provider-level) | -- | Guideline concordance, attitudes and barriers to guidelines, access to available guidelines | 2 years |
| Morgenstern et al., 2003 [53] | Quasi-experiment, pre-post comparison | Multi-component acute stroke treatment education program | Community laypersons (patient-level); Community- and ED-based physicians and EMS responders (provider-level); Stroke care policies (organization-level) | 15 months | Number of acute stroke patients who received intravenous tissue plasminogen activator | 6 months |
| Bere et al., 2006 [54] | Controlled trial, pre-post comparison | (1) Fruit and vegetable education program | School-age students (patient-level) | 1 year | All-day fruit and vegetable intake | 1 year |
| Shepherd et al., 2000 [55] | Systematic review of controlled comparisons with pre-post analysis | Health education interventions that promote sexual risk reduction in women | Sexually active women in any setting, treated by any provider type (patient-level) | Varied from 1 day to 3 years (most lasted 1 to 3 months) | Behavioral outcomes (e.g, condom use, fewer partners, or abstinence, fewer STDs) | Varied from 1 month to 6 months (most were up to 3 months) |
Note. To identify studies that measured sustainability, we searched PubMed for reports that included any follow-up analyses of interventions or program effects, using keyword searches for terms such as 'sustain,' 'sustained,' 'sustainability,' and 'follow-up.'
Figure 2Site-level performance for hepatitis A screening in HIV patients before, during and after a one-year-implementation trial. Indicated by letter and number, sites implemented either clinical reminders (R), collaboratives (C), or both (C+R).
Recommendations for designing a sustainability evaluation
| • Don't measure sustainability of interventions that were not useful or didn't achieve a credible level of success. |
| • Know what particular components of the intervention were actually implemented and/or adapted, and measure sustainability from both a process and outcome point of view. |
| • Understand the assignable causes of sustainability failure and success. |
| • Allow enough time for performance to decline to its nadir. |
| • The longer the follow-up period, the better. |
| • Build in a follow-up evaluation into the original analytic plan to avoid later challenges, if possible. |
| • Use more than one method to triangulate qualitative information with quantitative data information. |
| • Talk directly to local stakeholders to understand the how and why behind |
| • performance measurements. |
| • Beware of drawing inappropriate conclusions (e.g., outcome attribution failure). |
| • Build the follow-up period into the original proposal if possible. |
| • Look for funding opportunities that explicitly include a sustainability component – either in the primary grant or through an allowable extension. |
| • For post hoc-designed analyses, look for small, rapid-response grants. |
| • Begin to routinize follow-up measurement as the responsibility of local stakeholders. |